One Pager as on March 31, 2023
Rule based diversification for optimum performance in changing market cycles | |
Aim to provide stability of large caps and growth of mid caps | |
Active stock selection through internal process framework for better return potential | |
Sector | MMLMCF | Nifty Large and Mid Cap 250 Index |
Financial Services | 23.97% | 27.96% |
Capital Goods | 13.57% | 6.96% |
Information Technology | 11.52% | 9.28% |
Oil Gas & Consumable Fuels | 8.54% | 7.59% |
Automobile And Auto Components | 6.67% | 6.99% |
Data as on March 31, 2023
Security | % to Net Assets |
HDFC Bank Limited | 6.24% |
Reliance Industries Limited | 5.47% |
Infosys Limited | 4.89% |
LTIMindtree Limited | 3.38% |
Larsen & Toubro Limited | 2.89% |
Cummins India Limited | 2.76% |
Bharat Forge Limited | 2.58% |
Tech Mahindra Limited | 2.50% |
ICICI Bank Limited | 2.35% |
Steel Authority of India Limited | 2.32% |
Total | 35.38% |
Fresh Additions | Complete Exits |
Security | Security |
AIA Engineering Limited | Mahindra & Mahindra Limited |
IDFC Limited | |
KEI Industries Limited | |
Mahindra CIE Automotive Limited |
Note: The companies/stock(s) referred above are only for the purpose of disclosure of significant portfolio
changes during the month and should not be construed as recommendation to buy/sell/ hold. The fund manager
may or may not choose to hold these companies/stocks, from time to time. Investors are requested to consult
their financial, tax and other advisors before taking any investment decision(s). Data as on March 31, 2023.
Turnover Ratio (Last 1 year) | 1.19 |
Standard Deviation | 15.67% |
Beta1 | 0.86 |
Sharpe Ratio# | 1.23 |
Jenson's Alpha2 | 0.0156 |
#Risk-free rate assumed to be 7.79% (MIBOR as on 31-03-23) - Source: www.mmda.org
1. Beta is calculated on the basis of average monthly rolling returns as of last day of the month
since inception till March 31, 2023 and annualized. 2. Calculated for the period since inception till
March 31, 2023. | Data Source: ICRA Analytics, Bloomberg | Data as on March 31, 2023
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Dec-19.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Since inception returns of the scheme is calculated on face value of Rs. 10 invested at inception. The performance details provided above are of Growth Option under Regular Plan. Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. *Based on standard investment of Rs. 10,000 made at the beginning of the relevant period. Mr. Manish Lodha is managing this scheme since December 21, 2020. Mr. Abhinav Khandelwal is managing this scheme since February 1, 2022.
^Benchmark ^^Additional Benchmark. CAGR – Compounded Annual Growth Rate. Inception/Allotment date: 30-Dec-19.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. Returns greater than 1 year period are compounded annualized. For SIP returns, monthly investment of equal amounts invested on the 1st business day of every month has been considered. CAGR Returns (%) are computed after accounting for the cash flow by using the XIRR method (investment internal rate of return).
^Benchmark CAGR – Compounded Annual Growth Rate. $Dedicated Fund Manager for Overseas Investments.
Past performance may or may not be sustained in future and should not be used as a basis of comparison with other investments. The performance details provided above are of Growth Option under Regular Plan Different Plans i.e Regular Plan and Direct Plan under the scheme has different expense structure. Mr. Manish Lodha is managing 10 schemes and Mr. Abhinav Khandelwal is managing 6 schemes of Mahindra Manulife Mutual Fund. The performance data for the schemes which have not completed one year has not been provided.
Performance as on March 31, 2023.
This product is suitable for investors who are seeking*:
• Long term wealth creation and
income;
• Investment predominantly in equity
and equity related securities of large
and mid cap companies.
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.